Login / Signup

Effect of Gubenyiliu formula II and its disassembled prescriptions on cell autophagy in breast cancer through PI3K/AKT/mTOR pathway.

Xiaojuan ChenGuoying JinHong LuoLifei Zhou
Published in: Anti-cancer drugs (2023)
Our study confirmed that GYII could treat breast cancer by restraining the PI3K/AKT/mTOR signaling pathway-mediated autophagy. While QX focuses on inhibiting tumor growth, FZ acts on inhibiting tumor metastasis.
Keyphrases